Industrial Design Innovation Achievement Exhibition

Exhibits
CR Sanjiu (Tangshan) Pharmaceutical Co., Ltd.
Company profile

Established in 1996, CR Sanjiu (Tangshan) Pharmaceutical Co., Ltd., located in the High-tech Zone of Tangshan city, is the first pharmaceutical company to specialise in the R&D of  Gynecological drugs and children’s medicine. In March 2007, the company joined the China Resources Pharmaceutical Group Limited (CR Pharma). CR Sanjiu (Tangshan) currently has more than 93 registered varieties, 24 independent intellectual property rights, and over 400 registered trademarks, including 3 in New Zealand. The company has formed 13 national regulations and obtained 14 new drug certificates, filling the gap in the domestic medicine market. To “offer overall treatment to female’s health, and help children grow healthily” as its mission, it builds the children’s medicine brand—Good Baby and the Gynecological drug brand—KANGFUTE. The children’s medicine of the company includes Jian’er Xiaoshi Oral Liquid, Ambroxol Hydrochloride Oral Solution, Pediatric Paracetamol and Amantadine Hydrochloride Granules, and Xiao’er Huatan Zhike Granule. The Gynecological drugs include Nifuratel and Nysfungin Vaginal Soft Capsules, and Compound Zedoary Turmeric Oil Suppositories.